Catalyst Wire Dossier Catalyst Wire Dossier

Pegylated Interferon Alpha-2a

pegylated interferon alfa-2a · F. Hoffmann-La Roche Ltd.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Pegylated Interferon Alpha-2a, covering 2011-01-07 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection [Phase 2]

See pricing